Impact of Germicidal Light
Withdrawn before enrolling · Not applicable
Conditions studied: Bacterial Transmission, S.Aureus Transmission, Operating Room Exposure to S. Aureus, 90-day Postoperative Surgical Site Infections, Superficial and Deep
In brief
Visible light at 405nm has been shown to be germicidal. The hypothesis is that use of this light (Indigo-Clean Lights) in operating rooms will reduce S. aureus transmission occurring within and between patients and reduce surgical site infections (SSIs). Investigators will evaluate a case-control study where patients undergoing surgery with the lights are matched with patients undergoing surgery without germicidal lights.
Key facts
- Study ID
- NCT03886337
- Run by
- University of Iowa
- People needed
- 0
- Starts
- 2022-05-01
- Expected to finish
- 2024-12-31
- Last updated by the study team
- 2020-03-05
Who can join
Age: 18 and older, up to 120. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Adult, at least 18 years old
- Adult patients undergoing orthopedic, cardiothoracic, gyn/onc, and neuro surgery and general anesthesia according to usual care with peripheral and/or central venous access.
You may not qualify if…
- Pediatric (<18 years old),
- Incarcerated, and/or
- Pregnant patients
- Undergoing surgery and/or without peripheral or central venous access.
- Undergoing surgery outside of the classifications above
Where it is running
- University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.